Clinical Trial Update: Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing insulin glargine to NPH insulin in adults with type 2 diabetes to assess progression of diabetic retinopathy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED